- Previous close
0.3900 - Open
0.3450 - Bid 0.3450 x --
- Ask 0.3900 x --
- Day's range
0.3400 - 0.3450 - 52-week range
0.2500 - 0.4800 - Volume
300 - Avg. Volume
5,885 - Market cap (intra-day)
195.566M - Beta (5Y monthly) 0.13
- PE ratio (TTM)
17.00 - EPS (TTM)
0.0200 - Earnings date 23 Oct 2024 - 5 Nov 2024
- Forward dividend & yield 0.01 (2.95%)
- Ex-dividend date 19 Aug 2024
- 1y target est
--
ISEC Healthcare Ltd., an investment holding company, provides medical care, consultancy, treatment, and surgery services in the field of ophthalmology in Singapore, Malaysia, and Myanmar. The company operates through two segments, Specialised Health Services and General Health Services. It offers a range of eye care services, including cataract and intraocular lens implant surgeries; refractive surgeries; vitreous and retinal diseases; cornea, external eye disease, and anterior surgeries; adult strabismus and paediatric ophthalmology, glaucoma diagnostics and therapeutics, medical retinal diseases, uveitis, oculoplastics, facial cosmetics, and aesthetics surgeries, as well as optometry and orthoptics. In addition, the company offers general medical services. It operates eye care centers in Kuala Lumpur, Melaka, Penang, Johor, Ipoh, Kampar, Kuching, and Sibu. The company was founded in 2007 and is headquartered in Singapore. ISEC Healthcare Ltd. operates as a subsidiary of Aier Eye International (Singapore) Pte. Ltd.
www.isechealthcare.com--
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Medical Care Facilities
Industry
Related news
View more
Performance overview: 40T.SI
Trailing total returns as of 23/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: 40T.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: 40T.SI
View moreValuation measures
Market cap
224.33M
Enterprise value
220.43M
Trailing P/E
16.74
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
3.16
Price/book (mrq)
2.71
Enterprise value/revenue
3.11
Enterprise value/EBITDA
9.85
Financial highlights
Profitability and income statement
Profit margin
18.87%
Return on assets (ttm)
10.28%
Return on equity (ttm)
16.57%
Revenue (ttm)
70.98M
Net income avi to common (ttm)
13.39M
Diluted EPS (ttm)
0.0200
Balance sheet and cash flow
Total cash (mrq)
15.87M
Total debt/equity (mrq)
14.23%
Levered free cash flow (ttm)
8.27M